# HKSTP Debuts at MEDICA 2026, Forging Hong Kong-Europe Pathways for Life and Health Tech

- Link: https://www.thailand-business-news.com/pr-news/hkstp-debuts-at-medica-2026-forging-hong-kong-europe-pathways-for-life-and-health-tech
- Published: 2026-11-20T18:20:00+07:00
- Author: Media OutReach

HONG KONG SAR / DÜSSELDORF, GERMANY – [Media OutReach Newswire](https://www.media-outreach.com)–
20 November 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) today
concluded its first-ever delegation of 22 park companies and local university partners
to MEDICA 2026 from 16 to 19 November in Düsseldorf, Germany. Joining hands with
the Hong Kong Trade Development Council (HKTDC), the Hong Kong MedTech Association,
the delegation has advanced new partnerships between Hong Kong, Germany and Europe,
while showcasing Hong Kong and the Chinese Mainland medical innovations at the world’s
leading trade fair for medical technology.

![HKSTP concluded its first-ever delegation of 22 park companies and local university
partners to MEDICA 2026 from 16 to 19 November in Düsseldorf, Germany.](https://
images.media-outreach.com/release.php/Thumb/1600x1066/842207/842207-Photo-1-jpg-
1600x1066.jpeg)

 _HKSTP concluded its first-ever delegation of 22 park companies and local university
partners to MEDICA 2026 from 16 to 19 November in Düsseldorf, Germany. _

 Landmark MoUs were signed by HKSTP with German healthtech ecosystem leaders Medical
Valley EMN and Kalms Consulting during the event. Such partnerships reinforce Hong
Kong’s status as a leading global hub for life and health tech innovation, offering
seamless access to the Chinese Mainland’s 390+ million citizens regularly using 
digital health services and China among the fastest-growing medical devices markets,
projected to reach USD 82 billion by 2032.

 The four-day event brought together global innovators to showcase technologies 
in surgical robotics, diagnostics, ophthalmology, rehabilitation and metabolic health.
Making its debut at MEDICA, HKSTP has fostered two-way ties between Hong Kong, Germany
and the Europe market empowering Chinese innovators to expand globally while opening
doors for European innovators seeking access to Hong Kong, the Greater Bay Area,
China and wider Asian region.

 **Mr Terry Wong, CEO of HKSTP**, said, “Turning breakthroughs into global healthcare
solutions requires deep ecosystem collaboration. At our MEDICA debut, engaging key
European partners such as Medical Valley EMN and Kalms Consulting is vital to building
trusted cross-border pathways for regulatory readiness and market access. Equally
exciting is seeing our park companies forge commercial partnerships and debut new
innovations on the global stage, demonstrating how HKSTP connects world-class R&
D with international markets to create lasting impact.”

 **Building Hong Kong-Europe Pathways for Healthcare Innovation**

 A key highlight at MEDICA 2026 was the signing of strategic MoUs between HKSTP 
and European partners. HKSTP signed an MoU with Medical Valley EMN to support market
access, business matching, clinical, research and innovation opportunities, and 
stakeholder engagement. HKSTP also signed an MoU with Kalms Consulting to strengthen
regulatory readiness and commercialisation for HKSTP companies entering European
markets, spanning advisory, market access, business development and facilitating
industry connections.

 HKSTP also provided a platform for park companies at MEDICA to advance international
partnerships and market expansion:

 *  **Orange Biotech**, a developer of low-cost CRISPR-based diagnostic testing 
   platforms, signed an MoU with Hungarian medical device company CorLab to explore
   distribution of its point-of-care diagnostic products in Hungary and the wider
   European Union, alongside regulatory, market-access and commercialisation activities
   and potential future manufacturing and assembly in Hungary.
 *  **Pushkang Biotechnology** signed a strategic cooperation agreement with Egypt-
   based Keen Diagnostic Partners (KDP) to introduce and commercialise its MS200
   Automated Chemistry Analyzer and related reagent panels in Egypt. Combining Pushkang’s
   microfluidic platforms with KDP’s local healthcare network, the partnership will
   drive product deployment, training, and market development, expanding access 
   to high-quality, cost-effective diagnostics across Egyptian hospitals and clinics.

 **Premiering Healthcare Innovation on the Global Stage**

 Alongside new partnerships, HKSTP park companies unveiled new healthcare technologies
to global audiences at MEDICA:

 *  AusMed Global has marked the European soft launch of KetoMetrics®, a CE-marked
   device and the world’s first portable, real-time breath ketone monitoring system
   delivering accuracy comparable to laboratory Gas Chromatography gold-standard
   testing. Designed for versatile deployment, KetoMetrics® empowers users in both
   point-of-care and home settings with quantitative metabolic insights to support
   weight management, wellness, sports performance, healthy ageing, and ketogenic
   interventions.
 *  **Dymind **has launched its upgraded, CE-marked DH-8000 haematology analysis
   workstation. Designed for large laboratories, this new premier analyser offers
   CBC, CRP, SAA and ESR testing, with expandable SPS and slide maker modules to
   boost efficiency.

 **Accelerating Two-Way MedTech Expansion Between Europe and Asia**

 HKSTP brought together global healthcare leaders to explore practical pathways 
for cross-border expansion. Speaking at MEDICA’s Market Entry Stage under the theme“
Unlocking Asia’s Growth – Hong Kong and HKSTP as the Launchpad for Life & Health
Tech”. Mr Terry Wong spotlighted Hong Kong’s research strengths, clinical resources,
and ecosystem as an ideal gateway for global innovators entering Asia.

 To deepen Asia-Europe ties, HKSTP co-hosted an executive roundtable with global
law firm Clifford Chance on MedTech collaboration, alongside delegation visits to
Siemens Healthineers, Würth Group, TUM Venture Labs, and SGS Germany GmbH. These
engagements sparked vital dialogue on regulation, commercialisation, investment,
and two-way market access.

 HKSTP curated targeted business matching sessions with industry leaders including
Deloitte, DQS, High-Tech Gründerfonds, Intertek, Kalms Consulting, SGS, and Tekno
Surgical to foster valuable connections and potential collaboration with ecosystem
partners across Europe.

 **Global Recognition for**** Hong Kong Life and Health Technology**

 HKSTP’s life science companies continue to earn top international recognition across
major global biotech competitions. At BioJapan 2026, **Excalipoint Therapeutics**
and **GenEditBio** took first and second place at the SHIC Fast Track. In the US,**
OncoImmunostics, Advanced Micro Integrations, and Rare Power** captured the Grand,
Gold, and Silver awards at the 2026 Washington Innovation & Entrepreneurship Competition.
These wins confirm Hong Kong’s ventures are clinically validated, investment-ready,
and primed for global healthcare breakthroughs.

 HKSTP supports more than 400 Life and Health Technology companies within an ecosystem.
Through funding, incubation programmes, infrastructure and industry connections,
HKSTP supports innovators from R&D and validation through to commercialisation and
international expansion.

 **Appendix: MEDICA 2027 – List of 22 exhibitors at Hong Kong Pavilion including
park companies outside the Hong Kong Pavilion (in** **alphabetical order)**

 1.   Agilis Robotics Limited
 2.   AusMed Global Limited
 3.   Baptist University
 4.   b-One Ortho (Hong Kong) Limited
 5.   Chinese University of Hong Kong
 6.   Hong Kong Dymind Biological Co., Limited
 7.   Eyebright Medical Technology (Hong Kong) Limited
 8.   HongKong Hugemed Holding Co., Limited
 9.   Hong Kong Polytechnic University
 10.  Hopebotics Limited
 11.  iBone Healthcare Limited
 12.  Kulia Labs HK Limited
 13.  Lasmx Trade Limited
 14.  MagMint Scientific Limited
 15.  Multera Limited
 16.  NeurOssence Bio Limited
 17.  Okosix (Ecotec Global Limited)
 18.  Orange Biotech Limited
 19.  Pushkang Biotechnology Limited
 20.  University of Hong Kong, Department of Orthopaedics and Traumatology
 21.  Wondfo Biotech (HK) Co., Limited
 22.  Yuanhua Robotics, Perception & AI Technologies (HK) Limited

Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

#### Hong Kong Science and Technology Parks Corporation

Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001
and has built a proven foundation as Hong Kong’s leading innovation and technology(
I&T) ecosystem. Established for 25 years, HKSTP is supporting 14 unicorns, has nurtured
more than 17,000 research professionals and built a community of over 2,500 technology
companies from 26 countries and regions across four strategic technology clusters:
Life and Health Technology, AI and Data Science, Microelectronics and Advanced Manufacturing,
and GreenTech and New Energy.

 As an ecosystem orchestrator, HKSTP provides end-to-end support to attract and 
nurture talent, accelerate commercialisation and help technology ventures scale.
Its innovation infrastructure spans over 240 hectares covering Hong Kong Science
Park in Pak Shek Kok, InnoCentre in Kowloon Tong, and three modern InnoParks in 
Tai Po, Tseung Kwan O and Yuen Long, advancing Hong Kong’s vision for new industrialisation
and smart manufacturing.

 Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen, strengthens cross-border
collaboration by connecting Hong Kong, the Chinese Mainland and global innovation
networks and propels Chinese innovators onto the world stage, while also delivering
comprehensive GBA landing support to accelerate cross-border success for local and
international ventures.

 As HKSTP enters its next chapter with strong foundations, it continues to deepen
impact, elevate quality and create value for innovators. As an ecosystem built to
lead change, HKSTP is empowering Hong Kong to define what comes next in innovation,
growth and opportunity.

 More information about HKSTP is available at [www.hkstp.org](https://apc01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hkstp.org%2F&data=05%7C02%7Cangela.lau%40hkstp.org%7Cf53d06ee1f3a4d39936808dd99da60bb%7Cb3e19ac2e19244c890bd41acbfb3dcdb%7C0%7C0%7C638835886263357391%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=fDDCG6clbTcPUhuSVBqZ3g2VlJJAyf%2FHP5KOyHOvWYk%3D&reserved=0).

![](//track.media-outreach.com/index.php/WebView/503064/36955)

**Source** : [HKSTP Debuts at MEDICA 2026, Forging Hong Kong-Europe Pathways for Life and Health Tech](https://www.media-outreach.com/news/hong-kong-sar/2026/11/20/503064/?rand=186006)

---

  |  This article was produced by Media OutReach, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not reflect the opinions of Thailand Business News. |

---

![Media OutReach Newswire](https://r2.thailand-business-news.com/wp-content/uploads/
2026/10/media-outreach-newswire-2025.svg)
